Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Axitinib × Lymphoid × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Genitourinary 8 Tumor-Agnostic 1 Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 1 Carcinoma 1

Interventions

Rituximab 29 Surveys and Questionnaires 25 Blood Specimen Collection 17 Gene Expression Profiling 15 Flow Cytometry 14 Polymerase Chain Reaction 13 Amplified Fragment Length Polymorphism Analysis 13 Microarray Analysis 11 Observation 10 Interviews as Topic 10 Psychiatric Rehabilitation 9 Lenalidomide 9 Immunohistochemistry 9 Cytogenetic Analysis 9 obinutuzumab 8 Watchful Waiting 8 Therapeutics 8 ibrutinib 7 Drug Therapy 7 Cyclophosphamide 7 Bendamustine Hydrochloride 7 Vincristine 6 Magnetic Resonance Spectroscopy 6 fludarabine 5 Prednisone 5 In Situ Hybridization, Fluorescence 5 Immunologic Techniques 5 Data Collection 5 Biopsy 5 zanubrutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00700258 2024-09-23

STAR-TOR

Pfizer

1,520 enrolled 24 charts

Carcinoma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡